Statement on new EU choline chloride anti-dumping measures
Rhea-AI Summary
Balchem (NASDAQ:BCPC) and Eastman welcomed the EU decision published on Dec 19, 2025 to impose anti-dumping duties of 90.0%–115.9% on choline chloride imports from China, effective for five years with possible renewal.
The producers say the measures protect EU food and feed supply chains, preserve jobs, support continued EU investment and innovation, and ensure supply stability and high health and safety standards. The statement also notes revised customs origin rules clarifying that liquid choline chloride retains Chinese origin if the key chemical reaction occurred in China, helping prevent circumvention.
Positive
- Anti-dumping duties set at 90.0%–115.9%
- Measures effective for five years with renewal possibility
- EU industry claims sufficient production capacity to serve full market demand
- Clarified origin rules to prevent circumvention of duties
Negative
- Company will monitor attempts to circumvent the measures
- Effective implementation depends on ongoing enforcement by authorities
News Market Reaction 1 Alert
On the day this news was published, BCPC gained 0.45%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers in Specialty Chemicals showed mixed, mostly modest moves (e.g., SXT +0.14%, CBT -1.33%, ESI -0.51%, SSL +0.65%, AXTA +0.38%), indicating BCPC’s -1.52% move was more stock-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 10 | Dividend announcement | Positive | +2.4% | Annual dividend raised 10.3%, seventeenth consecutive annual increase. |
| Oct 30 | Conference participation | Neutral | +0.2% | Management presenting at major industrial investor conference. |
| Oct 21 | Earnings results | Positive | +4.1% | Q3 2025 sales and earnings growth with stronger cash flow and lower net debt. |
| Oct 07 | Earnings call notice | Neutral | -1.4% | Announcement of timing and access details for Q3 earnings call. |
| Aug 26 | Conference participation | Neutral | +0.2% | Planned appearance at H.C. Wainwright global investment conference. |
Recent clearly positive fundamental and capital-return news (earnings, dividend increase) have coincided with positive one-day price reactions, suggesting the stock has generally responded constructively to favorable company developments.
Over the last six months, Balchem reported stronger Q3 2025 results on Oct 21, with net sales of $267.6M and net earnings of $40.3M, which coincided with a +4.06% one-day move. An annual dividend of $0.96 per share, a 10.3% increase, announced on Dec 10, also saw a positive +2.35% reaction. Multiple conference appearances and the Q3 call had smaller price impacts. Today’s EU anti-dumping decision directly relates to choline chloride, a product area highlighted in prior filings, adding a policy tailwind alongside earlier operational momentum.
Market Pulse Summary
This announcement details EU anti-dumping duties of 90.0%–115.9% on choline chloride imports from China, effective for five years. For Balchem, an EU producer, this supports the regional food and feed supply chain and reinforces prior disclosures that highlighted the pending investigation. Investors may monitor how these measures affect choline chloride pricing, capacity utilization, and future EU trade clarifications, alongside established financial drivers such as sales growth and cash generation seen in recent quarters.
Key Terms
anti-dumping duties regulatory
customs origin rules regulatory
trimethylamine hydrochloride technical
ethylene oxide technical
AI-generated analysis. Not financial advice.
EU producers laud EU for addressing choline chloride dumping by China; measures will help preserve jobs and secure feed supply chain
MONTVALE, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- As producers of choline chloride in the EU, Eastman and Balchem welcome the European Union's decision published on December 19, 2025 to adopt anti-dumping duties between 90.0 and
Defending fair trade in choline chloride is essential to preserving European jobs, encouraging industrial innovation, and supporting a strong and sustainable supply chain for EU food and feed.
Representatives of the EU producers express their companies’ gratitude to the European Commission, and in particular to the Directorate-General for Trade (DG TRADE), for its rigorous work, independence, and ongoing commitment to fair trade.
The EU industry, which has sufficient production capacities in place to accommodate the full EU market demand and growth for the foreseeable future, sees these measures as essential for assuring their ability to continue their investments in EU production, employment and innovation.
More generally, these measures allow the EU supply chain and EU consumers to have a healthy domestic EU choline chloride industry which can ensure supply stability and compliance with the highest health and safety standards. Especially in a time of geopolitical instabilities, the EU cannot afford to allow unfairly traded imports from China to make EU food and feed industries wholly dependent on Chinese suppliers.
The EU producers will continue to work closely with the European Commission and national authorities to ensure the effective implementation of these measures and to monitor any attempts to circumvent them. In this regard, the producers also welcome the recent clarifications of the customs origin rules which will help prevent circumvention of the anti-dumping measures via the placing of liquid choline chloride on a carrier in a country other than China. The origin rules now state that, for purposes of determining the origin of choline chloride products, the last substantial transformation which confers origin is the country where the chemical reaction for choline chloride between trimethylamine hydrochloride and ethylene oxide takes place. In other words, liquid choline chloride made in China and put on a carrier in a third country, e.g. Vietnam, still has Chinese origin upon importation into the EU.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
| Contact: | Jacqueline Yarmolowicz |
| Balchem Corporation | |
| (Telephone: 845-326-5600) |